StreetSpread · Technology · Kalshi

Will the FDA approve gedatolisib for HR+/HER2-, PIK3CA wild-type advanced breast cancer before Aug 1, 2026?

Technology Closes August 1, 2026 Kalshi

Kalshi's current ask is 80¢ for YES on this contract (80% implied). Closes August 1, 2026 (~26 days).

Live price

SideCentsImpliedVolume
Kalshi (yes ask)80¢80%$3K
Kalshi (yes bid)73¢73%—
Trade on Kalshi →
StreetSpread aggregates real-time odds across Kalshi, Polymarket, DraftKings, FanDuel, BetMGM, Caesars, and Fanatics. Prices update every ~30 seconds via WebSocket. Back to live tracker · Join the app waitlist.

Follow us: X (@thestreetspread) · Instagram (@thestreetspread) · LinkedIn